DRO2102 / URGUP23077 / Zhang
Basic Study Information
Purpose:
This study will establish the preferred dose of lisinopril in men with non-metastatic
prostate cancer undergoing radiation treatment. This study will also evaluate the
effect of lisinopril on urinary symptoms and the impact of lisinopril on biomarkers
and their association with urinary symptoms.
Location: Wilmot Cancer Institute
Lead Researcher (Principal Investigator)
Lead Researcher:
Hong Zhang
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search